Total Payments
$1,163
2023 Payments
$192.17
Companies
15
Transactions
31
Medicare Patients
5,097
Medicare Billing
$642,913
Payment Breakdown by Category
Food & Beverage$1,163 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,163 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $190.88 | 9 | $0 (2023) |
| Lilly USA, LLC | $157.37 | 6 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $124.96 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $122.08 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $116.87 | 1 | $0 (2018) |
| ABBVIE INC. | $100.00 | 1 | $0 (2022) |
| Mallinckrodt LLC | $99.52 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $91.48 | 1 | $0 (2017) |
| PFIZER INC. | $50.83 | 3 | $0 (2023) |
| Novo Nordisk Inc | $34.60 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $192.17 | 10 | Amgen Inc. ($74.99) |
| 2022 | $239.70 | 9 | ABBVIE INC. ($100.00) |
| 2021 | $16.86 | 1 | Amgen Inc. ($16.86) |
| 2020 | $24.29 | 1 | Amgen Inc. ($24.29) |
| 2019 | $95.04 | 2 | Lilly USA, LLC ($95.04) |
| 2018 | $378.60 | 6 | GlaxoSmithKline, LLC. ($122.08) |
| 2017 | $216.44 | 2 | SANOFI-AVENTIS U.S. LLC ($124.96) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/24/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.45 | General |
| 08/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes | ||||||
| 06/22/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/21/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Bone Health | ||||||
| 05/25/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Diabetes | ||||||
| 05/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Diabetes | ||||||
| 04/04/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Bone Health | ||||||
| 03/20/2023 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/21/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Bone Health | ||||||
| 01/20/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Oncology | ||||||
| 08/30/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Diabetes Care | ||||||
| 08/23/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Diabetes | ||||||
| 08/02/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Diabetes | ||||||
| 07/26/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Bone Health | ||||||
| 06/15/2022 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: VACCINES | ||||||
| 05/25/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/21/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Bone Health | ||||||
| 04/08/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Bone Health | ||||||
| 01/20/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Bone Health | ||||||
| 01/11/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Bone Health | ||||||
| 11/13/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Bone Health | ||||||
| 05/09/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $79.20 | General |
| Category: Diabetes | ||||||
| 05/09/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Diabetes | ||||||
| 06/30/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $122.08 | General |
| Category: VACCINES | ||||||
| 06/26/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,674 | 5,630 | $497,658 | $244,277 |
| 2022 | 18 | 1,794 | 4,760 | $456,813 | $239,104 |
| 2021 | 13 | 798 | 1,042 | $170,431 | $86,406 |
| 2020 | 16 | 831 | 1,024 | $156,868 | $73,125 |
Total Patients
5,097
Total Services
12,456
Medicare Billing
$642,913
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 35 | 3,540 | $111,540 | $65,118 | 58.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 356 | 579 | $123,612 | $46,725 | 37.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 237 | 381 | $106,284 | $43,408 | 40.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 311 | 311 | $59,924 | $38,999 | 65.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 53 | 60 | $27,252 | $12,509 | 45.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 165 | 166 | $15,432 | $11,934 | 77.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $7,189 | $5,887 | 81.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 171 | 172 | $6,362 | $5,065 | 79.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 30 | 30 | $8,574 | $4,820 | 56.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 66 | $9,554 | $3,552 | 37.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $3,184 | $1,932 | 60.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 69 | 79 | $6,699 | $1,774 | 26.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 40 | 75 | $4,803 | $818.24 | 17.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 25 | 25 | $906.00 | $736.25 | 81.3% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 15 | 15 | $1,885 | $516.60 | 27.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 41 | 44 | $4,005 | $367.62 | 9.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 25 | 25 | $250.00 | $85.25 | 34.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 29 | $203.00 | $31.12 | 15.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 265 | 438 | $119,304 | $57,249 | 48.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 30 | 2,580 | $79,080 | $44,176 | 55.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 313 | 493 | $102,144 | $39,227 | 38.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 278 | 278 | $52,070 | $35,850 | 68.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 65 | 65 | $21,100 | $18,136 | 86.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 180 | 183 | $16,452 | $12,523 | 76.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 110 | 127 | $17,909 | $7,685 | 42.9% |
About Paul Le
Paul Le is a Adult Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2015. The National Provider Identifier (NPI) number assigned to this provider is 1063804193.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Paul Le has received a total of $1,163 in payments from pharmaceutical and medical device companies, with $192.17 received in 2023. These payments were reported across 31 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,163).
As a Medicare-enrolled provider, Le has provided services to 5,097 Medicare beneficiaries, totaling 12,456 services with total Medicare billing of $642,913. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Medicine
- Location Philadelphia, PA
- Active Since 02/26/2015
- Last Updated 05/15/2024
- Taxonomy Code 207QA0505X
- Entity Type Individual
- NPI Number 1063804193
Products in Payments
- EVENITY (Biological) $190.88
- TOUJEO (Drug) $124.96
- BEXSERO (Biological) $122.08
- ZERBAXA (Drug) $116.87
- TRULICITY (Drug) $109.94
- VUITY (Drug) $100.00
- ACTHAR (Biological) $99.52
- MOUNJARO (Drug) $47.43
- ELIQUIS (Drug) $31.39
- Cologuard Collection Kit (Device) $20.65
- TRUMENBA (Biological) $19.44
- Ozempic (Drug) $17.15
- FREESTYLE LIBRE 2 (Device) $13.73
- TUDORZA PRESSAIR (Drug) $13.56
- XIFAXAN (Drug) $13.55
- JARDIANCE (Drug) $13.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Medicine Doctors in Philadelphia
Mr. Peter Honig, Do, DO
Adult Medicine — Payments: $187,100
Adult Medicine $187,100
Dr. Mark Watkins, Do, DO
Adult Medicine — Payments: $75,355
Adult Medicine $75,355
Dr. Harvey Spector, D.o, D.O
Adult Medicine — Payments: $21,425
Adult Medicine $21,425
Dr. James Tweedy, D.o, D.O
Adult Medicine — Payments: $1,969
Adult Medicine $1,969
Dr. Amy Orloff-Fine, Do, DO
Adult Medicine — Payments: $1,901
Adult Medicine $1,901
Dr. Agnes Simmons, M. D, M. D
Adult Medicine — Payments: $1,723
Adult Medicine $1,723